BCBS Florida Medical Policy Updates – October 2018

Click here to view the Florida Blue Cross Blue Shield Medical Policy Updates »

October 2018 Medical Policy Updates:

• Abatacept (Orencia ) Injection and Infusion
• Abemaciclib (Verzenio)
• Adalimumab (Humira ) Injection
• Afatinib (Gilotrif™) Tablets
• Alectinib (Alecensa )
• Anakinra (Kineret ) Injection
• Apremilast (Otezla ) Tablet
• Automated Percutaneous Discectomy, Laser Discectomy, Endoscopic Discectomy, or DISC Nucleoplasty™ as Techniques of Intervertebral Disc Decompression
• Brigatinib (Alunbrig)
• Brodalumab (Siliq ) Injection
• Cabazitaxel (Jevtana ) Injection
• Cardiac Monitoring Devices
• Ceritinib (Zykadia™) Capsules
• Certolizumab Pegol (Cimzia ) Injection
• Chemoresistance and Chemosensitivity Assays
• Crizotinib (Xalkori®) Capsules
• Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Dermatologic, or Prostate Tumors
• Dupilumab (Dupixent ) Injection
• Durable Medical Equipment (DME)
• Endometrial Ablation
• Enteral Formulas
• Erlotinib (Tarceva®) Tablets
• Etanercept (Enbrel ) Injection
• Extended-Release Tablet  Extended-Release Tablet
• Fosnetupitant-Palonosetron (Akynzeo) IV
• Gefitinib (Iressa)
• Genetic Testing
• Golimumab (Simponi , Simponi  Aria) Injection and Infusion
• Guselkumab (Tremfya ) Injection
• Immune Globulin Therapy
• Implantable Bone-Conduction and Bone-Anchored Hearing Aids
• Infertility
• Infliximab Products [infliximab (Remicade ), infliximab-dyyb (Inflectra ), and infliximab-abda (Renflexis )]
• Infrared Energy Therapy and Low Level Laser Therapy
• Inhaled Nitric Oxide
• Investigational Services
• Ixekizumab (Taltz ) Injection
• Lenvatinib (Lenvima )
• Minimally Invasive Fusion Techniques
• Mohs Micrographic Surgery
• Multigene Expression Assay for Predicting Recurrence in Colon Cancer
• Necitumumab (Portrazza )
• Nivolumab (Opdivo )
• Non-Covered Services
• Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions Using Cell-Free Fetal DNA
• Osimertinib (Tagrisso )
• Panniculectomy and Abdominoplasty
• PCSK9 Inhibitors
• Pegvaliase-pqpz (Palynziq )
• Percutaneous Vertebroplasty, Kyphoplasty, and Sacroplasty
• Physical Therapy (PT) and Occupational Therapy (OT)
• Preventive Services
• Prostate Saturation Biopsy
• Ramucirumab (Cyramza™) Injection
• Sacroiliac Joint Injections
• Sarilumab (Kevzara ) Injection
• Secukinumab (Cosentyx ) Injection
• Sleep Testing
• Temporary Prostatic Stent and Prostatic Urethral Lift
• Tendon Sheath, Ligament, and Trigger Point Injections
• Tocilizumab (Actemra ) Injection and Infusion
• Transcranial Doppler Studies
• Treatment of Hyperhidrosis
• Tumor/Genetic Markers
• Ustekinumab (Stelara ) Injection and Infusion
• Vedolizumab (Entyvio ) Infusion
• Vestibular Rehabilitation

Click here to view the Florida Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.